Stimulation of human neutrophil degranulation with 1-O-octadecyl-2-O-acetyl-SN-glyceryl-3-phosphorylcholine: modulation by inhibitors of arachidonic acid metabolism.
D015117:5,8,11,14-Eicosatetraynoic Acid / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology; D002396:Catechols / Q000494:pharmacology; D016861:Cyclooxygenase Inhibitors; D003571:Cytochalasin B / Q000494:pharmacology; D003594:Cytoplasmic Granules / Q000187:drug effects*; D006801:Humans; D016859:Lipoxygenase Inhibitors; D008244:Lysophosphatidylcholines / Q000494:pharmacology*; D009637:Masoprocol; D009113:Muramidase / Q000378:metabolism*; D009504:Neutrophils / Q000187:drug effects* / Q000201:enzymology; D010972:Platelet Activating Factor
D002396:Catechols; D016861:Cyclooxygenase Inhibitors; D016859:Lipoxygenase Inhibitors; D008244:Lysophosphatidylcholines; D010972:Platelet Activating Factor; D015117:5,8,11,14-Eicosatetraynoic Acid; D003571:Cytochalasin B; D009637:Masoprocol; D009113:Muramidase; D002118:Calcium